10 August 2021

Tonight: ATAGI co-chair on Moderna

Clinical

The Moderna mRNA vaccine has received TGA provisional approval.

Tonight’s COVID update will be delivered by Associate Professor Nigel Crawford, Co-chair of ATAGI. Nigel is uniquely positioned to explain the role of ATAGI and its relevance to the current pandemic.

In addition, he will cover the recent developments in the management of the Australian pandemic including: An overview of the newly available Moderna vaccination; how the currently available vaccinations in Australia compare in terms of effectiveness against the Delta variant at preventing severe diseases as well as transmission; the rationale and evidence behind the upcoming push for vaccinating children 12 yrs of age and older; an important update on the clinical features and management pathways for Pfizer-related myocarditis, pericarditis as well as AZ-related clots; and what we can learn from the experience of other countries who have been dealing with the Delta pandemic.

REGISTER HERE

Attendees will be eligible for:

RACGP: 4 CPD activity points

ACRRM: 2 hours under the educational activities category

Pharmacists: This activity has been accredited (Accreditation Number: A2108HED2) for 2 hours of Group 1 CPD (or 2 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan which can be converted to 2 hours of Group 2 CPD (or 4 CPD credits) upon successful completion of relevant assessment activities.

Don’t miss out, REGISTER NOW.

Topics include:

The Latest COVID Update

A/Prof Nigel Crawford – Infectious Disease Specialist; Co-Chair, ATAGI; Director, Surveillance of Adverse Events Following Vaccination In the Community (SAEFVIC), Murdoch Children’s Research Institute; Senior Medical Advisor, Victorian Department Health COVID19 Vaccine Safety Team

A/Prof Crawford will cover the recent developments in the management of the Australian pandemic including: An overview of the newly available Moderna vaccination; how the currently available vaccinations in Australia compare in terms of effectiveness against the Delta variant at preventing severe disease as well as transmission; the rationale and evidence behind the upcoming push for vaccinating children 12 yrs of age and older; an important update on the clinical features and management pathways for Pfizer-related myocarditis, pericarditis as well as AZ-related clots; and what we can learn from the experience of other countries who have been dealing with the Delta pandemic.

Depression and Menopause

Prof Jayashri Kulkarni – Psychiatrists; Director, Monash Alfred Psychiatry Research Centre (MAPrc); Head, Central Clinical School Department of Psychiatry

Depression is one of the most common symptoms of menopause. In this presentation, Prof Jayashri Kulkarni outlines a systematic approach to the assessment, investigation and treatment of the middle-aged woman presenting with depression. She will also include information about the natural history of mental illness at this time of life and how GPs can determine what treatment should take priority.

An Acne Update for GPs

Dr Ryan De Cruz – Specialist Dermatologist; Fellow of the Australasian College of Dermatologists (FACD), Head of Bone Marrow Transplant, Dermatology Clinic, The Royal Melbourne Hospital, Founder, Southern Dermatology

Melbourne dermatologist, Dr Ryan de Cruz presents what’s new in the understanding, assessment and treatment of acne, the very common and depressing skin condition not only of adolescents but also of young adults. In addition, Dr de Cruz will outline the latest evidence-based recommendations for prescription treatment and treatment combinations, will suggest effective adjunctive skincare and give practical indicators for when specialist referral is warranted.

Iron Deficiency and Chronic Disease

A/Prof David Colquhoun – Clinical Cardiologist; The Wesley Hospital, Brisbane

How common is iron deficiency in people with chronic disease and is it worthwhile treating? These are just two of the many questions about this tricky condition that will be answered by A/Prof David Colquhoun in his presentation as part of this webinar. In addition, the talk will cover the very practical considerations of which chronic diseases are most at risk of affecting iron stores and how iron deficiency associated with chronic disease is best managed in the primary care setting.

Cardio-Oncology: What GPS Need to Know

Dr Daniel Cehic – Cardiologist; Chief Medical Officer, Cardiology, GenesisCare

Oncology patients and their treating specialist tend to focus on overcoming the relevant cancer, understandably. But , as survival rates improve, attention must be paid to the cardiac health of these patients, cardiologist, Dr Daniel Cehic says. Cancer survivors are at increased risk of cardiac disease compared with the rest of the population and to make a difference, GPs need to take a pro-active  approach to the prevention, early detection and treatment of CVD in patients being treated for cancer as this presentation will explain.

PLEASE NOTE: Due to the high levels of traffic we experience and the new log in process to our website, please make sure you log in to the website 15 minutes prior to the start of the webcast to ensure that your viewing is not disrupted.

Date:

Tuesday 17 August

Time:

7:00pm – 9:00pm AEST (NSW, VIC, TAS, ACT, QLD)
6:30pm – 8:30pm ACDT (SA, NT)
5:00pm – 7:00pm AWST (WA)

COVID-19 live update